Increased risk of infection with SARS-CoV-2 Omicron BA.1 compared with Delta in vaccinated and previously infected individuals, the Netherlands, 22 November 2021 to 19 January 2022

Euro Surveill. 2022 Jan;27(4):2101196. doi: 10.2807/1560-7917.ES.2022.27.4.2101196.

Abstract

Infections with the Omicron SARS-CoV-2 variant are rapidly increasing worldwide. Among 174,349 SARS-CoV-2-infected individuals (≥ 12 years), we observed an increased risk of S gene target failure, predictive of the Omicron variant, in vaccinated (odds ratio (OR): 3.6; 95% confidence interval (CI): 3.4-3.7) and previously infected individuals (OR: 4.2; 95% CI: 3.8-4.7) compared with infected naïve individuals. This suggests vaccine- or infection-induced immunity against SARS-CoV-2 infections is less effective against the Omicron than the Delta variant.

Keywords: SARS-CoV-2 Omicron Variant of Concern Vaccine escape; air-borne infections; epidemiology; laboratory; severe acute respiratory syndrome - SARS; vaccines and immunisation; viral infections.

MeSH terms

  • COVID-19 Vaccines
  • COVID-19*
  • Humans
  • Netherlands
  • SARS-CoV-2*

Substances

  • COVID-19 Vaccines

Supplementary concepts

  • SARS-CoV-2 variants